From the American Society of Clinical Oncology (ASCO) 2020 Virtual Annual Meeting, we bring you trial updates including
KEYNOTE-408, PHERGain and KEYNOTE-061.
View the updates below:
Barbara Burtness
KEYNOTE-048: progression post next line for R/M HNSCC
Javier Cortes
PHERGain: chemo
de-escalation using
F-PET in HER2+
breast cancer
Charles Fuch
KEYNOTE-061:
pembro or paclitaxel for PDL1+ gastric cancer
